Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?

Bibliographic Details
Main Authors:	Fulvio A. Scorza, Josef Finsterer, Ana C. Fiorini
Format:	Article
Language:	English
Published:	SpringerOpen 2021-07-01
Series:	The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:	SARS-CoV-2 COVID-19 Parkinson’s disease Complications Movement disorder
Online Access:	https://doi.org/10.1186/s41983-021-00344-x

Similar Items

The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria
by: Josef Finsterer, et al.
Published: (2023-12-01)

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
by: Josef Finsterer, et al.
Published: (2021-10-01)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
by: Walaa A. Kamel, et al.
Published: (2021-09-01)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
by: Fulvio A. Scorza, et al.
Published: (2021-09-01)

Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
by: Josef Finsterer, et al.
Published: (2021-02-01)

Attribute fatal, multiple cavitary lesions with air-fluid levels and hemorraghe to SARS-CoV-2 or ECMO only after ruling out differentials
by: Josef Finsterer, et al.
Published: (2023-12-01)

Hypophysitis or pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2023-09-01)

SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
by: Josef Finsterer
Published: (2023-04-01)

Diagnosing SARS-CoV-2 vaccination associated rhombencephalitis requires comprehensive work-up and exclusion of differentials
by: Josef Finsterer, et al.
Published: (2022-03-01)

Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
by: Josef Finsterer, et al.
Published: (2022-09-01)

The etiology of SARS-CoV-.2 associated intra-cranial hemorrhage is broad
by: Josef Finsterer, et al.
Published: (2022-03-01)

Before blaming SARS-CoV-2 for venous sinus thrombosis in a septic patient, consider alternative etiologies
by: Josef Finsterer, et al.
Published: (2023-03-01)

Before diagnosing SARS-CoV-2 vaccination-associated polyradiculitis, alternative explanations must be ruled out
by: Ana Claudia Fiorini, et al.
Published: (2024-01-01)

Before blaming SARS-CoV-2 for intra-cerebral aneurysm formation and rupture, alternative mechanisms need to be ruled out
by: Josef Finsterer
Published: (2022-12-01)

Establishing causality between SARS-CoV-2 and stroke/bleeding requires a temporal relationship and plausible pathophysiology
by: Josef Finsterer, et al.
Published: (2023-09-01)

Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer, et al.
Published: (2023-09-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

SARS-CoV-2 in cardiomyocytes
by: Josef Finsterer
Published: (2021-11-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
by: J. Finsterer, et al.
Published: (2023-09-01)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
by: Iro Boura, et al.
Published: (2023-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
by: Josef Finsterer
Published: (2022-11-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
by: Jeremy M. Morowitz, et al.
Published: (2022-04-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Case report: Atypical Parkinsonism following SARS-CoV-2 infection
by: Paola Polverino, et al.
Published: (2023-07-01)

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
by: Tsepo Goerttler, et al.
Published: (2022-03-01)

Re-infections with SARS-CoV-2 require a clarification of favourable risk factors
by: Josef Finsterer
Published: (2023-11-01)

SARS-CoV-2-related cardiovascular complications in the tropics
by: Josef Finsterer, et al.
Published: (2022-12-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

Rule out differentials before blaming SARS-CoV-2
by: Josef Finsterer
Published: (2022-09-01)

Movement Disorders Induced by SARS-CoV-2 Infection: Protocol for a Scoping Review
by: Elena Cecilia Rosca, et al.
Published: (2022-02-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic
by: Marianna Capecci, et al.
Published: (2023-01-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)